Sep. 3 at 4:34 PM
Milestone Achieved:
#EnvoyMedical (NASDAQ:
$COCH) announced all patients in its pivotal trial of the Acclaim® fully implanted cochlear implant have reached the 3-month follow-up with no serious adverse events reported. With a 2027 FDA submission targeted, Acclaim could redefine hearing health by eliminating external hardware and offering discreet, all-day use.
https://prismmarketview.com/envoy-medical-hits-three-month-milestone-in-pivotal-trial-of-fully-implanted-cochlear-implant/